Clinical Trial Update: Safety and Efficacy of DCB-BO1301 in Advanced Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports safety and efficacy data for DCB-BO1301 in advanced melanoma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• DCB-BO1301

Snippet

Sponsor: Chung Mei Biopharma Co., Ltd | Conditions: Advanced Melanoma | Phase 1, Phase 2 | Status: UNKNOWN